HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sarah Bernard Selected Research
Sarah Bernard Research Topics
Disease
11
Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2011
4
Hypoxia (Hypoxemia)
01/2020 - 01/2017
3
Intellectual Disability (Idiocy)
06/2013 - 05/2002
2
Neoplasms (Cancer)
12/2021 - 07/2021
2
Dyspnea (Shortness of Breath)
01/2021 - 01/2020
2
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
06/2013 - 05/2013
1
Pulmonary Arterial Hypertension
01/2022
1
Melanoma (Melanoma, Malignant)
12/2021
1
Neoplasm Metastasis (Metastasis)
12/2021
1
Sleep Apnea Syndromes (Sleep Apnea)
01/2020
1
Obstructive Lung Diseases (Obstructive Lung Disease)
01/2017
1
Pulmonary Heart Disease (Cor Pulmonale)
11/2015
1
Pulmonary Hypertension
11/2015
1
Autism Spectrum Disorder
06/2013
1
Neurodevelopmental Disorders
06/2013
1
Mental Disorders (Mental Disorder)
09/2012
Drug/Important Bio-Agent (IBA)
9
Oxygen (Dioxygen)
IBA
01/2022 - 01/2015
2
inosine dialdehyde (inox)
IBA
01/2022 - 01/2017
2
Proteins (Proteins, Gene)
FDA Link
01/2022 - 12/2021
2
Methylphenidate (Ritalin)
FDA Link
Generic
06/2013 - 05/2013
1
Platinum
IBA
12/2021
1
Sirolimus (Rapamycin)
FDA Link
12/2021
1
Drug Combinations
IBA
12/2021
1
Everolimus
FDA Link
12/2021
1
Carboplatin (JM8)
FDA Link
Generic
12/2021
1
MTOR Inhibitors
IBA
12/2021
1
Glycopyrrolate (Glycopyrronium Bromide)
FDA Link
Generic
01/2020
1
Bronchodilator Agents (Bronchodilators)
IBA
01/2020
1
Tiotropium Bromide (Spiriva)
FDA Link
01/2020
1
indacaterol
IBA
01/2020
1
Antipsychotic Agents (Antipsychotics)
IBA
09/2012
1
Complement System Proteins (Complement)
IBA
08/2011
1
Prednisone (Sone)
FDA Link
Generic
01/2011
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2011
Therapy/Procedure
10
Therapeutics
01/2022 - 11/2015
1
Drug Therapy (Chemotherapy)
12/2021
1
Laparotomy
07/2021
1
Nephroureterectomy
07/2021
1
Activities of Daily Living (ADL)
01/2021
1
Respite Care
05/2002